The Valley Desk

NCT03876028 · Interventional trial

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Overall registry status Terminated

Phase 1

Conditions Diffuse Large B-cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov